Epoch Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144M Sell
119,698
-3,118
-3% -$3.19M 0.82% 28
2026
Q1
$113M Sell
122,816
-17,615
-13% -$17.9M 0.68% 49
2025
Q4
$151M Sell
140,431
-33,942
-19% -$32.5M 0.86% 29
2025
Q3
$133M Sell
174,373
-980
-0.6% -$729K 0.73% 47
2025
Q2
$137M Buy
175,353
+4,299
+3% +$3.34M 0.71% 45
2025
Q1
$141M Sell
171,054
-13,634
-7% -$11.3M 0.73% 41
2024
Q4
$143M Sell
184,688
-60,006
-25% -$49.7M 0.69% 40
2024
Q3
$217M Sell
244,694
-33,041
-12% -$29.7M 0.97% 17
2024
Q2
$251M Sell
277,735
-33,912
-11% -$27.1M 1.15% 12
2024
Q1
$242M Sell
311,647
-258,894
-45% -$184M 1.08% 9
2023
Q4
$333M Buy
570,541
+243,555
+74% +$142M 1.51% 7
2023
Q3
$176M Sell
326,986
-55,734
-15% -$28.7M 1.12% 14
2023
Q2
$179M Sell
382,720
-19,157
-5% -$8.03M 1.04% 15
2023
Q1
$138M Sell
401,877
-3,376
-0.8% -$1.14M 0.82% 27
2022
Q4
$148M Buy
405,253
+84,149
+26% +$29.8M 0.88% 26
2022
Q3
$104M Sell
321,104
-130,705
-29% -$41.4M 0.68% 42
2022
Q2
$146M Sell
451,809
-8,383
-2% -$2.52M 0.86% 25
2022
Q1
$132M Sell
460,192
-12,360
-3% -$3.18M 0.65% 40
2021
Q4
$131M Buy
472,552
+179,329
+61% +$45.5M 0.66% 37
2021
Q3
$67.7M Buy
293,223
+4,555
+2% +$1.12M 0.38% 89
2021
Q2
$66.3M Buy
288,668
+4,720
+2% +$948K 0.36% 100
2021
Q1
$53M Buy
283,948
+127,642
+82% +$25M 0.25% 127
2020
Q4
$26.4M Buy
156,306
+42,601
+37% +$6.36M 0.12% 167
2020
Q3
$16.8M Sell
113,705
-8,505
-7% -$1.32M 0.08% 178
2020
Q2
$20.1M Buy
122,210
+49,997
+69% +$7.67M 0.1% 164
2020
Q1
$10M Buy
+72,213
New +$9.92M 0.06% 204

Other funds holding LLY

Epoch Investment Partners's LLY Position: Q2 2026 in Review

Epoch Investment Partners reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $3.19M and leaving 119,698 shares worth $144M. The position accounts for 0.82% of the portfolio, ranked #28.

Epoch Investment Partners first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. The position peaked at $333M in Q4 2023. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Epoch Investment Partners held 119,698 shares of Eli Lilly worth $144M as of Q2 2026.
  • Epoch Investment Partners sold 3,118 Eli Lilly shares in Q2 2026, an estimated $3.19M.
  • Eli Lilly made up 0.82% of Epoch Investment Partners's portfolio in Q2 2026, its #28 holding.
  • Epoch Investment Partners first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • Epoch Investment Partners's Eli Lilly position peaked at $333M in Q4 2023.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.